Showing results (191-200 of 408) with videos related to

Sort By:
Pageof 41
Journal of Neurology|March 26, 2025
MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS RegisterAgni-Maria Konitsioti, Sarah Laurent, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Epilepsy as a predictor of disease progression in multiple sclerosisMatthias Grothe, David Ellenberger, Felix von Podewils, et al.
BMC Musculoskeletal Disorders|March 1, 2011
Study protocol: improving patient choice in treating low back pain (IMPACT-LBP): a randomised controlled trial of a decision support package for use in physical therapyShilpa Patel, Sally Brown, Tim Friede, et al.
The American Journal of Cardiology|May 19, 2016
Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic CardiomyopathyJoachim Seegers, Leonard Bergau, Pascal Muñoz Expósito, et al.
Statistics in Medicine|November 28, 2019
Adaptive trial designs in diagnostic accuracy researchAntonia Zapf, Maria Stark, Oke Gerke, et al.
Multiple Sclerosis and Related Disorders|February 21, 2022
Managing neuropsychological impairment in multiple sclerosis - Controlled study on a standardized metacognitive intervention (MaTiMS)Jana Pöttgen, Tim Friede, Stephanie Lau, et al.
Systematic Reviews|July 1, 2022
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocolThomas Lehnert, Christian Röver, Sascha Köpke, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severityPeter Huppke, Hanna Hummel, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
Pageof 41